Showing results (11-20 of 725) with videos related to
Sort By:
Pageof 73
Breast Cancer Research and Treatment|October 11, 2014
Small molecule 1'-acetoxychavicol acetate suppresses breast tumor metastasis by regulating the SHP-1/STAT3/MMPs signaling pathwayJieqiong Wang, Li Zhang, Guoliang Chen, et al.British Journal of Pharmacology|July 28, 2017
Inhibition of histone deacetylases sensitizes EGF receptor-TK inhibitor-resistant non-small-cell lung cancer cells to erlotinib in vitro and in vivoWeiwei Yu, Weiqiang Lu, Guoliang Chen, et al.Oncotarget|June 16, 2016
Inhibiting cytoplasmic accumulation of HuR synergizes genotoxic agents in urothelial carcinoma of the bladderJiawei Guo, Jing Lv, Siyu Chang, et al.Cancer Research|July 2, 2009
Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesisXiufeng Pang, Zhengfang Yi, Xiaoli Zhang, et al.Cancer Research|January 17, 2009
Morelloflavone, a biflavonoid, inhibits tumor angiogenesis by targeting rho GTPases and extracellular signal-regulated kinase signaling pathwaysXiufeng Pang, Tingfang Yi, Zhengfang Yi, et al.Cancer Research|February 18, 2010
Celastrol suppresses angiogenesis-mediated tumor growth through inhibition of AKT/mammalian target of rapamycin pathwayXiufeng Pang, Zhengfang Yi, Jing Zhang, et al.Journal of Cancer Research and Clinical Oncology|September 16, 2011
Prognostic significance of vascular endothelial growth factor expression in gastric carcinoma: a meta-analysisJing Chen, Tao Li, Yuanyuan Wu, et al.Cancer Science|November 20, 2010
Hispidulin, a small flavonoid molecule, suppresses the angiogenesis and growth of human pancreatic cancer by targeting vascular endothelial growth factor receptor 2-mediated PI3K/Akt/mTOR signaling pathwayLijun He, Yuanyuan Wu, Lei Lin, et al.Molecular Cancer Therapeutics|March 5, 2011
(-)-Gossypol suppresses the growth of human prostate cancer xenografts via modulating VEGF signaling-mediated angiogenesisXiufeng Pang, Yuanyuan Wu, Yougen Wu, et al.JCI Insight|June 8, 2018
Repurposing sertraline sensitizes non-small cell lung cancer cells to erlotinib by inducing autophagyXingwu Jiang, Weiqiang Lu, Xiaoyang Shen, et al.Pageof 73